Navigation Links
Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
Date:2/21/2008

PITTSBURGH, Feb. 21 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) announced today that it has revised the time of its conference call and live webcast for the quarter and nine months ended Dec. 31, 2007, on Wednesday, Feb. 27, 2008, to 5 p.m. ET from 10:30 a.m. as previously announced.

The dial-in number to access the call is 877-874-1586 or 719-325-4814 for international callers. A replay, available for approximately eight days, will be available at 888-203-1112 or 719-457-0820 for international callers, with access pass code 8774583.

To access a live webcast of the call, please log on to Mylan's Web site (http://www.mylan.com) at least 15 minutes before the event is to begin to register and download or install any necessary software. A replay of the webcast will be available on http://www.mylan.com for approximately eight days.

Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ingredient (API) manufacturers in the world. Dey L.P., Mylan's fully integrated specialty business, provides the Company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas.

For more information about Mylan, visit http://www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Mylan Announces Final FDA Approval for Carvedilol Tablets
3. Mylan Announces Tentative FDA Approval for Topiramate Capsules
4. Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
5. Mylan Announces Extension of Tender Offers for Its 5.750% Senior Notes due 2010 and 6.375% Senior Notes due 2015
6. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
7. Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
8. Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
9. Mylan Announces Appointment of Harry A. Korman as President, North America
10. Mylan Announces Appointment of John Montgomery as President, Asia Pacific
11. Mylan Announces Management of Specialty Business, Dey L.P.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...d to cause illness may improve survival in people ...ew studies, HIV-positive people who were also infe...ger than other people infected with HIV. Researche...as GB virus C, improves survival by keeping HIV fr...
...rist acts in New York and Washington DC, air trans... several days, which severely affected the product... radiopharmaceuticals are shipped via air due to t...re either radioactive themselves or they are pharm...
..., fruit, and milk may reduce the risk of lung canc...elopment of cancer. Eating large amounts of fish c...repeatedly warn that fish consumption may only hav...me that it is safe to carry on smoking as long as ...
...does not help the sickest patients, according to t... lungs - the alveoli - are progressively destroyed... cannot do everyday activities like climbing stair... studies seemed to suggest that lung reduction sur...
Other Medicine News:
(Date:9/5/2008)...MAN, Mich., Sept. 5 /- When Michigan,... in a whitetail deer at a deer farm in,Kent County...remaining deer,on the farmer,s property and began ... industry is issuing the following statement on th...d at the Kent County Farm., The deer farm industr...
(Date:9/5/2008)...H SAN FRANCISCO, Calif., Sept. 5 /PRNewswire-First...cused on small molecule LFA-1 inhibitors,to treat ..., Inc. (Nasdaq:,SNSS) today announced SARcode,s in...lecule LFA-1 product candidate for T-cell mediated...into a license agreement providing,SARcode with an...
(Date:9/4/2008)...51 awarded orphan designation for the treatment of...emia, PRINCETON, N.J., Sept. 4 /- Ce.... Food & Drug Administration (FDA) has granted orp...ubicin) Liposome Injection,for the treatment of Ac... preparing to conduct two randomized Phase 2,studi...
(Date:9/4/2008)...tice Bulletin for Obstetrician-Gynecologists State... Change-Minimally Invasive Interventional,Radiolog...th Uterine,Fibroids, FAIRFAX, Va., Sept. 4 /PRNew... Radiology, a national organization of nearly 4,50...als dedicated to improving health,care through min...
Breaking Medicine Technology:Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm 2Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm 3SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Monogram Biosciences to Present at the ThinkEquity Partners Fifth Annual Growth Conference 437 1Monogram Biosciences to Present at the ThinkEquity Partners Fifth Annual Growth Conference 437 2Tulane University to receive 2414M for international HIV AIDS program 780 1Tulane University to receive 2414M for international HIV AIDS program 780 2New AHIP Report Takes a Ten Year Look at the Unintended Consequences of State Efforts to Change the Insurance Market 778 1New AHIP Report Takes a Ten Year Look at the Unintended Consequences of State Efforts to Change the Insurance Market 778 2Multi Year Compendium of Pharmaceutical Case Studies Available from Best Practices LLC 776 1Multi Year Compendium of Pharmaceutical Case Studies Available from Best Practices LLC 776 2
...FirstCall/ --,Medivation, Inc. today announced tha...rn time on Monday, June 11, to discuss top-line,12...placebo-controlled Phase 2 clinical trial of Dimeb... disease. , Rachelle Doody, M.D., Ph.D., lead inve...results for the first time at a,scientific meeting...
...Inovio Biomedical,Corporation (AMEX:INO), focused ... infectious diseases and a novel alternative to,su...that the,company,s partner, Vical Incorporated, pr...ata on 18 subjects from an ongoing Phase I,clinica...for,intratumoral delivery into melanoma tumors of ...
Other Medicine Technology:Medivation to Host Conference Call to Discuss Top-Line 12-Month,Results From Dimebon Alzheimer's Disease Study 2Medivation to Host Conference Call to Discuss Top-Line 12-Month,Results From Dimebon Alzheimer's Disease Study 3Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 2Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 3Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 4Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 5
...demand environments like OB/GYN, ER/Trauma, ICC/CC... delivers precision and control, plus consistent h...FESKIN* SATIN PLUS* Sterile Singles delive...excellent tactile sensitivity. The gloves are powd...
UROLOGY DRAPE. Soft translucent material for excellent shape conformity. Latex finger cot with additional adhesive ring around base. Full-width 50mm adhesive strip for secure fixing, with finger lift
NEAR-SkinTM Incise Drape Aggressive adhesive with no residue High moisture permeability for extended adhesion Low-glare matte finish film Product number identification
...the Penilab IV and the Penilab V have an exception...al studies. Model 1060 is similar to the Model 10...can one be added later. The Penilab V has a Doppl...of the accessories you'll need to get started. La...
Medicine Products: